Pharmaceutical manufacturers of Heparin sodium

Aspen CDMO offers customized manufacturing services for Finished Dosage Forms across two continents: Europe and Africa. The primary dosage forms include injectables such as pre-filled syringes, liquid and lyophilized vials, BFS ampoules, and infusion bags, as well as tablets, creams, ointments, sprays, and BFS ampoules for nebulizers. It operates three advanced facilities in France.

Our objective is to pave the path to a more wholesome future. However, we are also concerned about the manner in which we collectively achieve this goal. Being a company whose products impact the well-being of individuals worldwide, we uphold ourselves to a stringent standard and anticipate others to treat us likewise. We are advocates of transparent, truthful, and principled operation with the utmost level of ethics and honesty. This encompasses ensuring the company's compliance with all relevant laws and regulations on a global scale.

Established in 1978 as a specialized facility for Small Volume Parenterals (SVPs), Gland Pharma has evolved into a forward-thinking and quality-focused organization catering to the pharmaceutical requirements of diverse global markets. The company possesses state-of-the-art facilities for injectables established in partnership with Vetter Group, Germany, providing Gland Pharma a technological advantage in injectables, particularly in Pre Filled Syringes.

Established in 1993, SUANFARMA is a business-to-business partner in the field of life sciences specializing in the formulation, manufacture, and marketing of components for the pharmaceutical, veterinary, and nutraceutical sectors. In SUANFARMA, we provide our CDMO capabilities for fermentation and chemical synthesis projects, delivering a comprehensive service with a proven track record, facilitating success in the formulation, expansion, production, and marketing of an API, whether it is innovative or generic

HELM AG, a company based in Hamburg and owned by a family, has a 120-year history in 4 diverse sectors: Pharmaceuticals, Chemicals, Crop Protection, and Crop Nutrition. With a global presence through subsidiaries, sales offices, and partnerships, HELM is recognized as one of the world's leading independent marketing firms for chemicals. At HELM Pharma, our goal is to establish ourselves as the top B2B project and marketing platform, offering a distinctive partnership experience. In the marketing of our products, we deliver a comprehensive range of services for our business associates.

PI Corporation is the one of top Japanese manufacturers of Active Pharmaceutical Ingredients (APIs)*, and intermediates to provide to pharmaceutical companies. We offer services in a wide range; focusing mainly in the CDMO (Contract Development and Manufacturing Organization) business of APIs and intermediates, we provide a rapid and accurate response to a variety of clients’ needs in synthetic route design, manufacturing process, pilot manufacturing /investigational medical manufacturing, and commercial manufacturing.

Researching, isolating and developing new and safer biological active pharmaceutical ingredients for human use have been Opocrin’s core business since 1964. From the small Research Laboratory founded by pharmacologist Prof. Pietro Bianchini, Opocrin has become a world leader in the production of heparin derivatives and one of the biggest players in the active pharmaceutical ingredient sector.

The origins of Shenzhen Hepalink can be dated back to 1986 when it was known as Chongqing Tongda Bio-product Co. With over 31 years of experience in heparin research and production, Hepalink has established itself as one of the leading suppliers of heparin sodium API globally. Employing state-of-the-art equipment, Hepalink ensures the production of the highest quality and safest products. Additionally, it serves as a supplier to well-known pharmaceutical companies worldwide. The Hepalink group utilizes the heparin sodium API platform to expand its industry chain from crude heparin to preparations, thereby contributing to the assurance of heparin quality.

We take pride in being a company where our employees can experience joy and contentment, while consistently showing appreciation and regard for our clients, suppliers, and advocates in the nearby community. Furthermore, our goal is to be an endlessly ambitious creator of products that benefit society and the environment, manufacturing them in a safe and secure manner. We don't settle for the status quo, but rather approach our work with imaginative innovation to enhance our products and management, and to increase our personal capacity. We are joined by employees who possess a sense of purpose and responsibility in all their actions and are dedicated to working with dignity.

Biofer SpA is an independent Italian company, globally recognized for the development, production and marketing of different families of APIs and committed to promoting human well-being through scientifically advanced solutions of exceptional quality.

Scientific Protein Laboratories LLC (SPL) manufactures cGMP bulk active pharmaceutical ingredients (APIs) supplied to pharmaceutical and biopharmaceutical firms globally. Key offerings comprise of heparin sodium and pancreatic enzymes. SPL stands as one of the largest autonomous suppliers of heparin sodium and pancreatic enzymes globally, with more than three decades of expertise. The company possesses proficient capabilities in the extraction and refinement of active substances.

Wanbang Biopharmaceuticals specializes in the development, production, and distribution of pharmaceuticals tailored to patients with diabetes and associated cardiovascular conditions. Its range of products encompasses animal insulin, Glimepiride tablets, Meglumine Adenosine Cyclophosphate, EPO, Bangtan (Telmisatan), and Heparin sodium. In addition, the company offers aloe compound capsules designed to promote liver-heat clearance and bowel relaxation, among other benefits.

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd (hereinafter referred to as NKF) is located in Nanjing High-Tech Zone, Nanjing, China covering an area of about 40 mu (approximately 26,669 square meters). NKF is recognized as a High Tech Enterprise of Nanjing City, Jiangsu Province. Established in 1986 as an API producer, we focus on research, production and sales of raw material medicines of heparin sodium. As of today, NKF owns two subsidiaries and two holding subsidiaries and its registered capital is 36 million dollars US. Our output of heparin sodium accounts for 20% of the world’s heparin sodium.

Yantai Dongcheng Biochemicals is among the leading producers of biochemical API in China. The company's range of products has been shipped to over fifty nations. Key offerings such as Heparin Sodium, Chondroitin sulphate, Cytochrome C, Hyaluronic Acid, Collagen, and Glucosamine etc adhere to the EP, JP and USP standards. The company has achieved U.S. FDA site audit approval and holds German Hamburg GMP certificate and European CEP certificate for Heparin Sodium. Additionally, for Chondroitin sulphate, the company has obtained FDA DMF registration number and European CEP certificate

Documentation Master File, Postal Code, Written Verifications, Finished Dosage Form, Costs, Intellectual Property Rights, Patents and Market Exclusivities, Portfolio, Producer, Permitting, Distributing, Providers, News Roman Industries